Welcome to UCL Queen Square Institute of Neurology. Our mission is to translate world class neuroscience discovery research into treatments for patients. We train the next generation through PhD & MSc programmes. Director Prof Michael Hanna (tweets from our director signed MGH)
Join the Industry Masterclass in Drug Discovery & Development (10 July, London): a one-day programme with industry experts sharing how discoveries move to patients + what makes an investable programme.
Details: https://t.co/OiacagpJTY
@UCLBrainScience@UCLIoN
Excited to be new UCL Pro Vice Provost & support colleagues and contribute to the new UCL health strategy at a time that AI and digital will likely revolutionise health care- UCL can lead globally-https://t.co/jbK2XSh9mx
@uclh@UCLBrainScience@UCLIoN@uclnews@acmedsci
Only 11 days left to register and a few seats remaining! Register now for the UCL Queen Square Movement Disorders Centre Symposium on 10th June.
Registration closes 7th June.
🚨 Flyer out! The next Queen Square Basal Ganglia Club meeting will host Prof. Olivier Rascol and Prof. Manju Kurian on Therapy Development in Movement Disorders.
🗺️ NHNN, Wolfson Lecture Theatre
🗓️ 17/06/2026, 4 pm
All are welcome.
Please RT
@kailashbhatia@UCLIoN@UCLIoN_DCMN@MDC_IoN_UCL@neurolib
We’re recruiting a Senior Research Technician to work on Huntington’s disease and DNA repair modifier biology. A fantastic opportunity to be part of Prof Sarah Tabrizi’s collaborative lab team at @UCLIoN@UKDRI.
Apply here by 26 May👇
https://t.co/wEELDVf4f5
Delighted to be speaking at Venture Café Manchester on Thursday 23rd April about how neurotechnology is translating from research breakthroughs into real world use, covering progress in brain computer interfaces and neurotherapies. @DNS_UOM@UCLIoN@GJBrainResearch@mern_UoM
Delighted to open the 19th UK NMD Translational research conference-in Cambridge - dramatic progress in diagnosis and gene therapies for patients with Neuromuscular Diseases @MDUK_News@UCLIoN@uclh@UCLBrainScience@UCL_QS_CNMD@uclnews
Delighted to be in Cambridge for UCL/UCLH at Life Arc Mito National Translational Centres meeting-
Great progress in precision diagnostics, biomarkers and therapies @cam_mito @LondonMito @MDUK_news @UCLIoN @UCLBrainScience @uclh
🚨 Flyer out! The next Queen Square Basal Ganglia Club meeting will host Prof. Josep Dalmau and Prof. Bettina Balint on Movement Disorders and Autoimmunity.
📍 NHNN, London
📷 4pm
All are welcome.
Please 🔁
@kailashbhatia@UCLIoN@UCLIoN_DCMN@MDC_IoN_UCL@neurolib
🚨 SAVE THE DATE
The Queen Square Basal Ganglia Club Meetings are back.
We’re kicking off 2026 by hosting Prof. Josep Dalmau and Prof. Bettina Balint with a fantastic session on Movement Disorders and Autoimmunity.
📍 NHNN, London
🗓️ 29/04/2026
🕓 4 PM
All are welcome.
Please 🔁
@kailashbhatia@UCLIoN@UCLIoN_DCMN@MDC_IoN_UCL@QS_RareMD
One letter. One family. One historic breakthrough 🧠
This #BrainAwarenessWeek, hear the story of Carol Jennings – whose courage helped Professor Sir John Hardy (@UCLIoN) make a breakthrough in understanding Alzheimer's.
What can a brain reveal after death? 🤔
Marking #BrainAwarenessWeek, Dr Zane Jaunmuktane’s online lecture explores how donated brains help scientists understand disease onset, spread, and the future of brain research.
📅 17 March 13:00 – 14:00
Register👇 https://t.co/jXSkpQcZ7V
This #IWD2026 we spotlight Prof Sarah Tabrizi - leader in #Huntingtonsdisease research and long-standing BNA member. Sarah reflects on:
• Resilience in long-term research
• Her connection with patients
• Advice for ECRs
@UCLIoN@ucl@UCLHD
https://t.co/TOPsV9ZiP4
Prof Paola Giunti, head of the Ataxia Centre @UCLIoN@uclh has been invited to attend All Party Parliamentary Group (APPG) on #Genetic Rare Undiagnosed Conditions to continue the discussion on issues to get early access of newly MHRA approved drugs to patients with #RareDiseases
For decades, Duchenne muscular dystrophy was a diagnosis without treatment. Today, RNA-based therapies can modify the disease at its molecular source. The Novo Nordisk Foundation awards the 2026 Novo Nordisk Prize to Francesco Muntoni for pioneering work that helped make this possible.
By developing exon-skipping RNA therapies, Muntoni and collaborators showed that faulty genes could be bypassed - restoring some of the missing dystrophin protein in patients.
“It showed that genetic intervention was not just theoretical - it was biologically possible.”
His work helped pave the way for the first approved RNA-based medicines for Duchenne muscular dystrophy and established RNA correction as a viable therapeutic strategy across genetic medicine.
Francesco Muntoni will deliver a public lecture at the University of Copenhagen on 23 April 2026 in connection with the award ceremony.
#NovoNordiskPrize #RNAtherapy #GeneticMedicine
Read more: https://t.co/wAZtlfaXMz
Ten years ago, five rare dementia groups united to create Rare Dementia Support, building on roots that began in 1994 with a nurse-led FTD group at @UCLIoN Today we support 9,000+ members. This #RareDiseaseDay, thank you to everyone who’s been part of our journey.💜 @BrainAppeal
Congratulations to the University College London’s Selina Wray, Ph.D., recipient of the #AAICNeuro Excellence in Neuroscience Mentoring Award. A tireless advocate for mentoring early stage researchers, Dr. Wray is dedicated to supporting those under-represented in science, providing personal mentorship and hosting research placements for students who are the first in their families to study at university.
This is such amazing news!
Congratulations from all of us at Alzheimer's Research UK to Dr Selina Wray who's received the #AAICNeuro Excellence in Neuroscience Mentoring Award.